|
Cristiano, R J (1998) Viral and non-viral vectors for cancer gene therapy. Anticancer Res 18:3241-5
|
|
Cristiano, R J (1998) Targeted, non-viral gene delivery for cancer gene therapy. Front Biosci 3:D1161-70
|
|
Xu, B; Wiehle, S; Roth, J A et al. (1998) The contribution of poly-L-lysine, epidermal growth factor and streptavidin to EGF/PLL/DNA polyplex formation. Gene Ther 5:1235-43
|
|
Cristiano, R J; Xu, B; Nguyen, D et al. (1998) Viral and nonviral gene delivery vectors for cancer gene therapy. Cancer Detect Prev 22:445-54
|
|
Roth, J A; Cristiano, R J (1997) Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 89:21-39
|
|
Nguyen, D M; Wiehle, S A; Koch, P E et al. (1997) Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex. Cancer Gene Ther 4:191-8
|
|
Nguyen, D M; Wiehle, S A; Roth, J A et al. (1997) Gene delivery into malignant cells in vivo by a conjugated adenovirus/DNA complex. Cancer Gene Ther 4:183-90
|
|
Cristiano, R J; Roth, J A (1996) Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor. Cancer Gene Ther 3:4-10
|
|
Nguyen, D M; Spitz, F R; Yen, N et al. (1996) Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer. J Thorac Cardiovasc Surg 112:1372-6;discussion 1376-7
|
